Latest Expert Opinions

Signal
Opinion
Expert
BUY
BUY
December 12, 2013

It has a secular, long term theme away from cash to electronic payments. Generating wonderful returns for shareholders. They are almost a technology play. Follow it along with a stop loss.

Show full opinionHide full opinion
Mastercard Inc. (MA-N)
December 12, 2013

It has a secular, long term theme away from cash to electronic payments. Generating wonderful returns for shareholders. They are almost a technology play. Follow it along with a stop loss.

BUY
BUY
December 12, 2013

He prefers secular theme in web based retail. Then he prefers the high end and then the low end so he would be a shareholder here.

Show full opinionHide full opinion
Dollarama Inc. (DOL-T)
December 12, 2013

He prefers secular theme in web based retail. Then he prefers the high end and then the low end so he would be a shareholder here.

BUY
BUY
December 12, 2013

Strong shareholder relations. Is one he likes and owns. Almost made it a Top Pick today. They have a lot of north-south exposure. Benefit from improvement in the auto sector. Earnings per share should accelerate over the next couple of years. A well run railway. Operating ratio could improve.

Show full opinionHide full opinion

Strong shareholder relations. Is one he likes and owns. Almost made it a Top Pick today. They have a lot of north-south exposure. Benefit from improvement in the auto sector. Earnings per share should accelerate over the next couple of years. A well run railway. Operating ratio could improve.

DON'T BUY
DON'T BUY
December 12, 2013

One of the laggards in the pharma group. If a company can’t do well in a good market, then it is time to move on. Prefers JNJ-N for pharma exposure.

Show full opinionHide full opinion
Eli Lilly & Co. (LLY-N)
December 12, 2013

One of the laggards in the pharma group. If a company can’t do well in a good market, then it is time to move on. Prefers JNJ-N for pharma exposure.

HOLD
HOLD
December 12, 2013

REITs as a whole are having a tough time, but AMT is doing well relative to the rest. But there may be better sectors to be in at present. Prefers financials. If the sector turned up, this would be one of the better performers. Payout will continue to go up. 1.5% yield.

Show full opinionHide full opinion
American Tower (AMT-N)
December 12, 2013

REITs as a whole are having a tough time, but AMT is doing well relative to the rest. But there may be better sectors to be in at present. Prefers financials. If the sector turned up, this would be one of the better performers. Payout will continue to go up. 1.5% yield.

BUY
BUY
December 12, 2013

Prefers JNJ-N. Likes health care as a sector. Thinks this sector is set to do very, very well. Concerns about patent cliff have come and gone. Should have some decent dividend growth going forward. Has been consolidating with the market and now there is room to the upside.

Show full opinionHide full opinion
Merck & Company (MRK-N)
December 12, 2013

Prefers JNJ-N. Likes health care as a sector. Thinks this sector is set to do very, very well. Concerns about patent cliff have come and gone. Should have some decent dividend growth going forward. Has been consolidating with the market and now there is room to the upside.

BUY
BUY
December 12, 2013

One of the larger biotech companies. Biotech has been outperforming pharma. You can also look at BBH for exposure to the sector. Just pulled back into the moving averages.

Show full opinionHide full opinion

One of the larger biotech companies. Biotech has been outperforming pharma. You can also look at BBH for exposure to the sector. Just pulled back into the moving averages.